"Purdue was at the very center of the opioid crisis, fueling addictions and overdoses," said New York Attorney General Letitia James in a statement.

More than 80% of the settlement funds will go to state and local governments. The  remainder will go to those who directly ...

The Supreme Court blocked an earlier version of Purdue’s bankruptcy settlement. Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no ...

OxyContin manufacturer Purdue Pharma won court approval for an opioid-related settlement plan of at least $7.4 billion, clearing its path to exit from a six-year bankruptcy and resolve mass lawsuits ...

OxyContin maker Purdue Pharma urged a bankruptcy judge on Wednesday to approve a restructuring plan that includes a $7.4 ...

(The Hill) — The attorneys general of all 50 states, Washington, D.C., and four territories have agreed to sign on to a $7.4 billion settlement with Purdue Pharma and the members of the Sackler family ...

NEW YORK — A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits over the toll of opioids that includes some money ...

(NEW YORK) -- Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler ...